Episode 334: 333. Cell Phone Use While Driving and Financial Gain
Feedback and Financial Incentives for Reducing Cell Phone Use While Driving: A Randomized Clinical Trial | Public Health | JAMA Network Open | JAMA Network Question Can behavioral interventions decr...
2 Okt 20248min
Episode 333: 331. Noncontrast CT Selected Thrombectomy vs Medical Management
Noncontrast CT Selected Thrombectomy vs Medical Management for Late-Window Anterior Large Vessel Occlusion | Neurology Most studies that have shown a benefit from endovascular thrombectomy (EVT) for i...
24 Sep 20246min
Episode 332: 330. Does a Multivitamine a Day Keep The Death Away?
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2820369With as many as 1 in 3 US adults using multivitamin supplements, the question as to whether these supplements reduce mortality They ...
18 Sep 20246min
Episode 331: 329. Should We Give AceI or ARBs to Patients with CKD 4 and 5?
https://www.acpjournals.org/doi/10.7326/M23-3236Angiotensin-converting–enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) seldom are initiated among patients with chronic kidney disease (...
17 Sep 20247min
Episode 330: 328. Methods Monday, Composite Endpoints
Composite outcomes You add multiple outcomes together… this is great because you can increase the event rate.. if you are just looking at death lots of people might now die but if you look at death an...
16 Sep 202411min
Episode 329: 327. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening "SHIELD TESTING"
ening, the offer of a blood-based screening test boosted CRC screening by 17.5 percentage points over usual care.That is becauseCRC screening proportions were 17.5 percentage points higher in the bloo...
23 Aug 202412min
Episode 328: 327. Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk
https://pubmed.ncbi.nlm.nih.gov/38945140/The primary outcome was a composite of myocardial infarction, revascularisation, hospitalisation for heart failure, stroke, or death from cardiovascular causes...
2 Aug 20247min
Episode 327: 326. Should We Prescribe Inhaled Insulin? INHALE-3 TRIAL
INHALE-3, a randomized trial, 123patients with type 1 dm that compared the efficacy of an inhaled insulin regimen (Afrezza) plus degludec insulin (Tresiba®) against usual care over 17 weeks The study'...
1 Aug 20247min
